Astellas Turns to AAV-based Gene Therapy with Taysha Gene Therapies Collaboration Deal

By Ashish Tripathi

Pharma Deals Review: Vol 2022 Issue 11 (Table of Contents)

Published: 9 Nov-2022

DOI: 10.3833/pdr.v2022.i11.2746     ISSN: 1756-7874

Section: Licensing



In a bid to bolster its neurology pipeline, Astellas has entered into a collaboration agreement with Taysha Gene Therapies in a deal worth up to US$50 M...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details